Melatonin alleviates oxidative stress and pyroptosis, improves LPS-induced depressive-like behavior, and provides a novel therapeutic approach for depression by inhibiting the activation of the NLRP3 inflammasome in microglia. The gene discussed is NLRP3; the disease is depressive symptom measurement.